{
    "code": "60001147",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001147",
    "time": "2023-08-10 22:25:43",
    "許可證字號": "衛部菌疫輸字第001147號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/01\/21",
    "發證\/登錄日期": "110\/01\/21",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000114701",
    "中文品名": "多髓易濃縮輸注液20毫克\/毫升",
    "英文品名": "SARCLISA concentrate for solution for infusion 20 mg\/mL",
    "適應症": "1. 與pomalidomide及dexamethasone併用，適用於先前曾接受過至少2種治療(包括lenalidomide 及一種蛋白酶體抑制劑)的多發性骨髓瘤成年病人。\r\n2. 與carfilzomib及dexamethasone併用，適用於先前曾接受過至少1種治療的多發性骨髓瘤成年病人。",
    "劑型": "27D注射液劑",
    "包裝": "5mL、25mL玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新成分",
    "監視期限": "115\/01\/21",
    "主成分略述": "isatuximab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "SANOFI-AVENTIS DEUTSCHLAND GMBH",
            "製造廠廠址": "BRUNINGSTRASSE 50,D-65926 FRANKFURT AM (MAIN) GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "台灣大昌華嘉股份有限公司高上倉",
            "製造廠廠址": "桃園市楊梅區高上路1段150號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區瑞坪里梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "SANOFI CHIMIE",
            "製造廠廠址": "9 QUAI JULES GUESDE, 94400 VITRY-SUR-SEINE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013008600",
            "成分名稱": "isatuximab",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "816823_Sarclisa 500mg label-110-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=004&Type=9"
        },
        {
            "title": "816822_Sarclisa 100mg label-110-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=003&Type=9"
        },
        {
            "title": "仿單核定本_1100901_Sarclisa 20mg_TWPI_CN_ (IKEMA+v3)-26Aug'21_CDE comments-clean-110-09-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=002&Type=9"
        },
        {
            "title": "817408_Sarclisa 100mg box-110-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=006&Type=8"
        },
        {
            "title": "817407_Sarclisa 500mg box-110-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=005&Type=8"
        },
        {
            "title": "Sarclisa 100mg-box-TW_-110-03-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=004&Type=8"
        },
        {
            "title": "Sarclisa 100mg-label-TW_-110-03-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=003&Type=8"
        },
        {
            "title": "Sarclisa-500mg box-TW_-110-03-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=002&Type=8"
        },
        {
            "title": "Sarclisa-500mg label-TW_-110-03-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001147&Seq=001&Type=8"
        }
    ]
}